Login

Journal Image
Inflammation & Allergy-Drug Targets
(Formerly Current Drug Targets - Inflammation & Allergy)
ISSN (Print): 1871-5281
ISSN (Online): 2212-4055
VOLUME: 5
ISSUE: 1
DOI: 10.2174/187152806775269303









Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis

img
Author(s): Luis Escribano, Cem Akin, Mariana Castells and Lawrence B. Schwartz
Pages 61-77 (17)
Abstract:
Patients with mastocytosis have symptoms related to the tissue response to the release of mediators from mast cells (MC), local mast cell burden or associated non-mast cell hematological disorders. MC contain an array of biologically active mediators in their granules, which are preformed and stored. MC are also able to produce newly generated membrane-derived lipid mediators and are a source of multifunctional cytokines. Mediator-related symptoms can include pruritus, flushing, syncope, gastric distress, nausea and vomiting, diarrhea, bone pain and neuropsychiatric disturbances; these symptoms are variably controlled by adequate medications. Management of patients within all categories of mastocytosis includes: a) a careful counseling of patients (parents in pediatric cases) and care providers, b) avoidance of factors triggering acute mediator release, c) treatment of acute and chronic MC-mediator symptoms and, if indicated, d) an attempt for cytoreduction and treatment of organ infiltration by mast cells.
Keywords:
Mastocytosis, mast cell-mediator related symptoms, treatment
Affiliation:
Hospital Ramon y Cajal, Servicio de Hematologia, Carretera de Colmenar Km. 9.1, Madrid 28034, Spain;